Your browser doesn't support javascript.
loading
Comparison of capability and health-related quality of life instruments in capturing aspects of mental well-being in people with schizophrenia and depression.
Helter, Timea Mariann; Coast, Joanna; Laszewska, Agata; Stamm, Tanja; Simon, Judit.
Affiliation
  • Helter TM; Department of Health Economics, Center for Public Health, Medical University of Vienna, Austria.
  • Coast J; Health Economics Bristol, Population Health Sciences, Bristol Medical School, University of Bristol, UK.
  • Laszewska A; Department of Health Economics, Center for Public Health, Medical University of Vienna, Austria.
  • Stamm T; Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Austria; and Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria.
  • Simon J; Department of Health Economics, Center for Public Health, Medical University of Vienna, Austria; and Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
BJPsych Open ; 8(4): e117, 2022 Jun 27.
Article in En | MEDLINE | ID: mdl-35758648
ABSTRACT

BACKGROUND:

There is increasing evidence that assessing outcomes in terms of capability provides information beyond that of health-related quality of life (HRQoL) for outcome evaluation in mental health research and clinical practice.

AIMS:

To assess similarities and differences in the measurement properties of the ICECAP-A capability measure and Oxford Capabilities Questionnaire for Mental Health (OxCAP-MH) in people with schizophrenia experiencing depression, and compare these measurement properties with those of (a) the EuroQol EQ-5D-5L and EuroQol Visual Analogue Scale (EQ-VAS) and (b) mental health-specific (disease-specific) measures.

METHOD:

Using data for 100 patients from the UK, measurement properties were compared using correlation analyses, Bland-Altman plots and exploratory factor analysis. Responsiveness was assessed by defining groups who worsened, improved or remained unchanged, based on whether there was a clinically meaningful change in the instrument scores between baseline and 9-month follow-up assessments.

RESULTS:

The two capability instruments had stronger convergent validity with each other (Spearman's rho = 0.677) than with the HRQoL (rho = 0.354-0.431) or the mental health-specific (rho = 0.481-0.718) instruments. The OxCAP-MH tended to have stronger correlations with mental health-specific instruments than the ICECAP-A, whereas the ICECAP-A had slightly stronger correlation with the EQ-VAS. Change scores on the capability instruments correlated weakly with change scores on the HRQoL scales (rho = 0.131-0.269), but moderately with those on mental health-specific instruments for the ICECAP-A (rho = 0.355-0.451) and moderately/strongly on the OxCAP-MH (rho = 0.437-0.557).

CONCLUSIONS:

Assessing outcomes in terms of capabilities for people with schizophrenia and depression provided more relevant, mental health-specific information than the EQ-5D-5L or the EQ-VAS. The ICECAP-A and the OxCAP-MH demonstrated similar psychometric properties, but the OxCAP-MH was more correlated with disease-specific instruments.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: BJPsych Open Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: BJPsych Open Year: 2022 Document type: Article Affiliation country: